Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.

[1]  T. Kodama,et al.  Immunohistochemical staining for P1 and P2 promoter‐driven hepatocyte nuclear factor‐4α may complement mucin phenotype of differentiated‐type early gastric carcinoma , 2009, Pathology international.

[2]  B. Spaulding,et al.  Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. , 2009, International journal of clinical and experimental pathology.

[3]  H. Asamura,et al.  Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. , 2008, Archives of pathology & laboratory medicine.

[4]  G. Kang,et al.  Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. , 2007, Archives of pathology & laboratory medicine.

[5]  H. Iwata,et al.  Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers , 2007, Modern Pathology.

[6]  M. Miyazaki,et al.  The expression of hepatocyte nuclear factor‐4&agr;, a developmental regulator of visceral endoderm, correlates with the intestinal phenotype of gastric adenocarcinomas , 2006, Pathology.

[7]  H. Aburatani,et al.  Dysregulated expression of P1 and P2 promoter‐driven hepatocyte nuclear factor‐4α in the pathogenesis of human cancer , 2006, The Journal of pathology.

[8]  R. Odze,et al.  Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. , 2005, Archives of pathology & laboratory medicine.

[9]  C. Gomez-Fernandez,et al.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. , 2005, American journal of clinical pathology.

[10]  P. Chu,et al.  Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. , 2004, American journal of clinical pathology.

[11]  H. Yokozaki,et al.  Estrogen receptors in gastric adenocarcinoma: A retrospective immunohistochemical analysis , 2004, Virchows Archiv A.

[12]  P. Chu,et al.  Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. , 2004, American journal of clinical pathology.

[13]  Hyunsoo Kim,et al.  Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. , 2003, Archives of pathology & laboratory medicine.

[14]  A. Gown,et al.  CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.

[15]  T. Irimura,et al.  Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma , 2003, Histopathology.

[16]  D. Faigel,et al.  Metastatic breast cancer manifested as refractory anemia and gastric polyps. , 2002, Southern medical journal.

[17]  C. Reis,et al.  Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma , 2002, Virchows Archiv.

[18]  S. Yoshida,et al.  Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. , 2001, Endoscopy.

[19]  H. Peterse,et al.  Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma , 2000, Cancer.

[20]  M. Sobrinho-Simões,et al.  Immunohistochemical Study of the Expression of MUC6 Mucin and Co-expression of Other Secreted Mucins (MUC5AC and MUC2) in Human Gastric Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  T. Tot.  The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[22]  T. Tot.  Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases. , 1999, Annals of diagnostic pathology.

[23]  L. Ferri,et al.  Linitis plastica as the first indication of metastatic lobular carcinoma of the breast: case report and literature review. , 1999, Canadian journal of surgery. Journal canadien de chirurgie.

[24]  D. Klimstra,et al.  Metastatic Breast Cancer Masquerading as Gastrointestinal Primary , 1998, American Journal of Gastroenterology.

[25]  P. Roepstorff,et al.  Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody , 1997, International journal of cancer.

[26]  J. K. Dunn,et al.  Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. , 1997, American journal of clinical pathology.

[27]  M. Borst,et al.  Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. , 1993, Surgery.

[28]  C. Ma,et al.  Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  R. Moll,et al.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.

[30]  J. Lamovec,et al.  Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study , 1991, Journal of surgical oncology.

[31]  O. Kojima,et al.  Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody , 1991, Cancer.

[32]  M. Wick,et al.  Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. , 1989, Human pathology.

[33]  A. Howell,et al.  A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. , 1984, British Journal of Cancer.

[34]  A. Gad,et al.  Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma. , 1975, Journal of clinical pathology.